Lobaplatin, Raltitrexed

DRUG2 trials

Sponsors

Zhujiang Hospital

Conditions

Hepatocellular Carcinoma ResectableLiver, Cancer of, Primary Resectable

Phase 3

Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial

RecruitingNCT05701436

Zhujiang HospitalLiver, Cancer of, Primary Resectable

Start: 2022-09-01End: 2026-03-01Target: 144Updated: 2023-03-02

Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial

RecruitingNCT05766605

Zhujiang HospitalHepatocellular Carcinoma Resectable

Start: 2023-01-01End: 2026-01-30Target: 90Updated: 2023-03-13